|
|
Volumn 53, Issue 3, 1997, Pages 435-452
|
|
Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
BACLOFEN;
DIAZEPAM;
PARACETAMOL;
PHENYTOIN;
TIZANIDINE;
ARTICLE;
BRAIN INJURY;
CLINICAL TRIAL;
DOSE CALCULATION;
DROWSINESS;
DRUG ABSORPTION;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG METABOLISM;
DRUG TOLERABILITY;
HALLUCINATION;
HUMAN;
INTRAPERITONEAL DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
LIVER TOXICITY;
MEAN ARTERIAL PRESSURE;
MUSCLE REFLEX;
MUSCLE TONE;
MUSCLE WEAKNESS;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
SOMNOLENCE;
SPASTICITY;
SPINE INJURY;
VERTIGO;
XEROSTOMIA;
|
|
EID: 0030936913
PISSN: 00126667
EISSN: None
Source Type: Journal
DOI: 10.2165/00003495-199753030-00007 Document Type: Article |
|
Times cited : (207)
|
|
References (112)
|
